FEATURING
- We are thrilled to welcome you back to Washington DC for the in-person/hybrid PCF Congress!
- Join us live to take advantage of numerous interpersonal networking opportunities with colleagues and educational opportunities at our robust exhibit hall with our industry partners
- An invitation-only, closed-door Chief Compliance Officer (CCO) Roundtable on the morning of Tuesday, October 25
For more information contact pcf.org.info@gmail.com.
- Annual reports and updates provided by DOJ, FDA, and OIG
- Over 30 current topics addressing crucial ethics, compliance and legal issues
- An industry-only, closed-door session for pharma and device ethics, compliance and legal professionals on Wednesday, October 26
KEYNOTE SPEAKERS
Catherine (Katie) Gray, PharmD
Acting Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD
Mary A. Inman, JD
Whistleblower Counsel; Partner, Constantine, San Francisco, CA and London, UK
Kelly Begg Lawrence, JD
Assistant US Attorney & Chief, Health Care Fraud, District of Massachusetts, US Department of Justice, Boston, MA
Glenn Leon, JD
Incoming Fraud Section Chief, Criminal Division, US Department of Justice; Former SVP & Chief Ethics & Compliance Officer, Hewlett Packard, Washington, DC
Mary E. Riordan, JD
Senior Counsel, Office of Counsel to the Inspector General, Office of the Inspector General, US Department of Health and Human Services, Washington, DC
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, HHS Office of Counsel to the Inspector General, Washington, DC
Jamie Yavelberg, JD
Director, Fraud Section, Civil Division, US Department of Justice, Washington, DC
FEATURED FACULTY
Khelin N. Aiken, JD
Partner, North America FDA Practice, Baker McKenzie; Former Regulatory Counsel, FDA
Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP
Kristiana Bankova, MS
Senior Manager Forensics, EY
Samantha Barrett Badlam, JD
Counsel, Ropes & Gray
Eric M. Baim, MA, JD
Partner, Dovetail Consulting Group LLC; Former VP Compliance US, Shire
Rachel Batykefer
Senior Director, Integrity & Compliance CIA Operations, Mallinckrodt
Ann E. Beasley, JD
Chief Compliance Officer, Zai Lab
Allison Benkert, MBA
Director Global Compliance Investigations, Seagen
Joshua Blank, JD
Senior Attorney, Arnold & Porter
Jennifer Bragg, JD
Partner, Skadden Arps LLP
Adam L. Braverman, JD
Partner, Morrison & Foerster, Former US Attorney, Southern District of California
Terra Buckley, JD
Vice President, Head of Compliance Advisory Services, MedPro Systems; Vice President Compliance, Mesoblast
Susy Cardoso, JD, LLM
Former Executive Director of Ethics & Compliance, Amarin
Craig Carpenito, JD
Partner, King & Spalding; Former US Attorney, New Jersey
Cheryl Chamallas
Sr. Director, Global Compliance Risk, argenx
Masha Chestukhin, MSJ
Associate Director, Compliance Officer R&D, IA, FMV, Sanofi Genzyme
Steven Cohen, MBA
Associate Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly
Mahnu V. Davar, MA, JD
Partner, Arnold & Porter
Jake DeBoever, JD
Vice President, Chief Compliance Officer, Dermavant Sciences
Gildas Durand
Partner/Principal, Forensic & Integrity Services, EY
David Falcone
Associate Vice President Global Compliance, Merz Aesthetics
J. Mark Farrar, CPA, CFE, CFF, MSJ, CIPP/US
Managing Director, Epsilon Life Sciences LLC
Nicole L. Felician, JD
Executive Director, Legal Regulatory, Digital Health, Patient Centricity, Cell Therapies, Astellas Pharma US
Kellie Fidler, PMP
Senior Director, Compliance Risk Assessment, Monitoring and Operations, Bristol-Myers Squibb
Bethany Fox, JD
Vice President, Commercial Legal Affairs, Exelixis
Sara Frank, JD
Principal, Choate, Hall & Stewart LLP
Cari A. Gallman, JD
Senior Vice President, Chief Compliance and Ethics Officer, Bristol Myers Squibb
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda
Gary F. Giampetruzzi, JD
Partner, Paul Hastings
Edward P. Glynn, MBA
Principal, EY
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, USDOJ
Tom Gregory
Partner, Forensic & Integrity Services, EY
Noor Haq, CCEP, MS, MBA, CIA
Executive Director, US Compliance, Amgen
Saul B. Helman MD, MBA
President, Epsilon Life Sciences
Michael Hercz, JD
Senior Vice President & General Counsel, Sentynl
Emily F. Hodge, JD
Partner, Choate, Hall & Stewart LLP
Todd Haugh, JD
Associate Professor of Business Law and Ethics, Kelley School of Business, Indiana University
Brenna E. Jenny, JD
Partner, Sidley
Andrea Kocharyan, JD
Vice President, Head of Legal and Compliance, Zealand Pharma
Daniel Koerner
Senior Director, Potomac River Partners
JJ Kuhn, JD
Vice President, Chief Counsel, Global Investigations, Medtronic
Stephanie Kurteff, JD, HCCP
Head of Compliance, Healthcare Compliance Officer, Medicines360
Rebekah Latchis, JD
Senior Director, Americas Office of Ethics and Compliance, Medtronic
Kirsten Liston
Principal and Founder, Rethink Compliance
Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting US Attorney, Massachusetts, DOJ
Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding
Jim Massey, MS
Chief Sustainability Officer, Zai Lab
Chris C. Matteson
US Forensics Compliance Services Executive, Forensic & Integrity Services, EY
Kirstin Mayer, JD
Head of US Compliance, Argenx
Dana S. McMahon, JD
Vice President, Global Chief Compliance Officer, Stryker
Rore Middleton, JD
Vice President, Compliance and Ethics at Blueprint Medicines, Member of Chief
Gregory F. Noonan, JD
Partner, Hogan Lovells; Former AUSA, Massachusetts & Southern District of California
Katherine Norris, MPA
Managing Director, Epsilon Life Sciences
Kristen Oberg, JD
Senior Vice President, Legal & Compliance, Mycovia Pharmaceuticals
